Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial (2019)
- Authors:
- Autor USP: CASTRO JUNIOR, GILBERTO DE - FM
- Unidade: FM
- DOI: 10.1093/annonc/mdy545
- Subjects: IMUNOHISTOQUÍMICA; ANTINEOPLÁSICOS; NEOPLASIAS PULMONARES; CÉLULAS CULTIVADAS DE TUMOR
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Annals of oncology
- ISSN: 0923-7534
- Volume/Número/Paginação/Ano: v. 30, n. 2, p. 281-289, 2019
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
HERBST, R. S et al. Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial. Annals of oncology, v. 30, n. 2, p. 281-289, 2019Tradução . . Disponível em: https://doi.org/10.1093/annonc/mdy545. Acesso em: 10 fev. 2026. -
APA
Herbst, R. S., Baas, P., Perez-gracia, J. L., Felip, E., Kim, D. -W., Han, J. -Y., et al. (2019). Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial. Annals of oncology, 30( 2), 281-289. doi:10.1093/annonc/mdy545 -
NLM
Herbst RS, Baas P, Perez-gracia JL, Felip E, Kim D-W, Han J-Y, Molina JR, Kim J-H, Arvis CD, Castro Junior G de. Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial [Internet]. Annals of oncology. 2019 ; 30( 2): 281-289.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1093/annonc/mdy545 -
Vancouver
Herbst RS, Baas P, Perez-gracia JL, Felip E, Kim D-W, Han J-Y, Molina JR, Kim J-H, Arvis CD, Castro Junior G de. Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial [Internet]. Annals of oncology. 2019 ; 30( 2): 281-289.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1093/annonc/mdy545 - Diagnóstico de mutações ativadoras do gene EGFR em adenocarcinomas pulmonares: caracterização e implicações clínicas
- Non-gastrointestinal stromal tumours soft tissue sarcomas: an update
- Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial
- Epidemiologia do câncer de pulmão
- Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus
- The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer
- Desenvolvimento de fármacos: pesquisa clínica e medicina de precisão
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- Expressão da proteína ERCC1 (Excision Repair Cross Complementing Group 1), do seu RNA mensageiro e de polimorfismos genéticos como fatores prognósticos em pacientes portadores de carcinoma epidermóide de cabeça e pescoço operados e submetidos à quimiorradioterapia adjuvante
- Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048
Informações sobre o DOI: 10.1093/annonc/mdy545 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
